pharmaphorum
JANUARY 27, 2022
Walter Greenleaf, PhD, neuroscientist and digital health expert at Stanford University’s Virtual Human Interaction Lab, tells us about the new book Applied Virtual Reality in Healthcare: Case Studies and Perspectives and why he and his co-authors gathered insights from some of the most prominent figures in the field of medical extended reality (XR).
Fierce Healthcare
JANUARY 27, 2022
MDLive rolls out virtual-first health monitoring program for chronic conditions. rtorrence. Thu, 01/27/2022 - 10:59.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Outsourcing Pharma
JANUARY 24, 2022
The CRO's work with La Jolla Institute for Immunology, centered on a unique mouse model, is intended to increase understanding of how the COVID-19 virus operates.
Pharma Marketing Network
JANUARY 27, 2022
Tune in to the Pharma Marketing Network and industry experts Novartis, UCB, GSK and others, for a fireside talk on hot topics around what has changed in the last year and how to align your pharma marketing strategies accordingly. Three Panels: . Engaging Oncologists in 2022. Emerging Digital Channels and Navigating the Social Landscape: What’s Hot, What’s Not, What’s the Next Big Thing.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
pharmaphorum
JANUARY 28, 2022
Digital health venture funding had a ridiculous, bonkers, blockbuster year. On this, everyone can agree, although longtime watchers of the industry will remember that we’ve heard that consistently for the last several years. But never mind, 2021 was a blockbuster even compared to 2020 or 2019, with many sources saying there was twice as much, or nearly twice as much money raised this past year compared with the year before.
Fierce Healthcare
JANUARY 25, 2022
Here's why UnitedHealth Group's CMO says virtual care is a 'game changer' to reach underserved populations. hlandi. Tue, 01/25/2022 - 16:19.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
The Physician Pharmacist
JANUARY 28, 2022
This article will serve as a comprehensive guide to help you understand all the hype about the MCAT! The MCAT, also known as the Medical College Admission Test, is a critical entrance-style exam that students are required to take to be considered for a seat in a medical school. As a pharmacy student, you probably have heard of this notorious test, but know little about the finer details!
pharmaphorum
JANUARY 24, 2022
In November, NICE backed NHS use of AstraZeneca’s diabetes and heart failure drug Forxiga for the treatment of chronic kidney disease. pharmaphorum caught up with AZ’s Joris Silon to discuss unmet needs in the condition. “Many times, I have talked to nephrologists who take care of patients with chronic kidney disease in the later stages, and they have a very simple message – and that is, if we really want to do something for these patients then we need to intervene earlier,” says Joris Silon, se
Fierce Healthcare
JANUARY 27, 2022
Chutes & Ladders—North Carolina HHS head joins Aledade; Uber Health adds first-ever chief medical officer. dmuoio. Thu, 01/27/2022 - 16:27.
Outsourcing Pharma
JANUARY 26, 2022
A leader from Elligo Health Research (a SCOPE 2022 exhibitor ) discusses flaws in traditional recruitment approaches and offers up some fresh new ideas.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharma Mirror
JANUARY 28, 2022
Singapore, Asia’s integrated healthcare company, Clearbridge Health Limite is pleased to announce that Labnovation Technologies, Inc.’s (“Labnovation”) COVID-19 Antigen Rapid (“ART”) Test Kit, which is imported by Clearbridge and registered for use in the Philippines, has been recently approved by the Food and Drug Administration (“FDA”) of the Philippines for self-testing.
pharmaphorum
JANUARY 26, 2022
Immunocore has secured a piece of biotech industry history, becoming the first company to get an FDA approval for a cancer therapeutic based on T cell receptor (TCR) technology. The US regulator cleared the company’s lead TCR Kimmtrak (tebentafusp; formerly IMCgp100 ) – a bispecific T cell engager (BiTE) that consists of a soluble TCR targeting gp100 expressed on cancer cells fused to a protein that binds CD3 receptors on lymphocytes – as a treatment for unresectable or metastatic uveal me
Fierce Healthcare
JANUARY 26, 2022
Senate health leaders preview bipartisan plan to overhaul the nation's public health response. dmuoio. Wed, 01/26/2022 - 12:17.
Outsourcing Pharma
JANUARY 25, 2022
Am expert from the CRO discusses unique challenges associated with running clinical trials that stretch across national boarders and how to conquer them.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharma Marketing Network
JANUARY 27, 2022
In partnership with Villanova University, Drexel University, Thomas Jefferson University, the University of the Sciences and Columbia Business School, the HBA continues to advocate for the connection between advanced education and advancement in the workplace. For Immediate Release: Philadelphia— January 18, 2022 — Today, the Mid-Atlantic Region and the Philadelphia Chapter of the Healthcare Businesswomen’s Association announced the curriculum for their Winter 2022 Master Class, a series of 5 on
pharmaphorum
JANUARY 28, 2022
Merck & Co has passed another milestone in its drive to move PD-1 inhibitor Keytruda earlier in the treatment pathway for cancer, with the European Commission approving use of the drug as post-surgery (adjuvant) therapy for renal cell carcinoma (RCC). Adjuvant treatment moves use of the drug into patients with earlier-stage cancer, a key strategy for Merck and other cancer immunotherapy companies as it expands the pool of patients eligible for treatment.
Fierce Healthcare
JANUARY 26, 2022
Number of ACOs increases modestly to 483 for 2022, which advocates say should be wake-up call. rking. Wed, 01/26/2022 - 13:36.
Outsourcing Pharma
JANUARY 28, 2022
A representative from IQVIA discusses the particulars of the US agencyâs new draft document and shares what it might mean for clinical trial data evaluation.
Pharma Marketing Network
JANUARY 27, 2022
In partnership with Villanova University, Drexel University, Thomas Jefferson University, the University of the Sciences and Columbia Business School, the HBA continues to advocate for the connection between advanced education and advancement in the workplace. For Immediate Release: Philadelphia— January 18, 2022 — Today, the Mid-Atlantic Region and the Philadelphia Chapter of the Healthcare Businesswomen’s Association announced the curriculum for their Winter 2022 Master Class, a series of 5 on
pharmaphorum
JANUARY 24, 2022
A private equity group has agreed to take over most of IBM Watson Health, seven years after the business was launched with a pledge to revolutionise healthcare data analysis. Francisco Partners is picking up a range of databases and analytics tools – including Health Insights, MarketScan, Clinical Development, Social Programme Management, Micromedex and other imaging and radiology tools – for an undisclosed sum estimated to be in the region of $1 billion.
Fierce Healthcare
JANUARY 26, 2022
Uber taps first chief medical officer for growing healthcare arm. rtorrence. Wed, 01/26/2022 - 16:24.
Outsourcing Pharma
JANUARY 26, 2022
The upcoming industry event offers attendees (in-person and virtual) a range of opportunities to learn, connect, and innovate, according to an organizer.
NICE
JANUARY 26, 2022
NICE has recently published a guideline on Shared decision making (nice.org.uk) (SDM) which defines SDM as a collaborative process involving a person and their healthcare professional working together to reach a joint decision about care. In essence, the clinician provides evidence-based information using a variety of tools and techniques to describe risks and benefits and encourages the person to express their beliefs, values, and choices.
pharmaphorum
JANUARY 25, 2022
The area of digital therapeutics is growing rapidly, and in this piece Ben Hargreaves examines why this is the case, how broadly these therapies can be applied and why investment in the area is mounting. To demonstrate how quickly the digital therapeutics space is developing, it is easiest to state that the first such therapy was approved in 2018 and since that point the annual investment in the space has more than doubled in the intervening years.
Fierce Healthcare
JANUARY 24, 2022
From full-page newspaper ads to press events, hospitals say their pandemic pleas are reaching the public. dmuoio. Mon, 01/24/2022 - 15:20.
Pharma Mirror
JANUARY 25, 2022
Waltham, Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced positive topline results from its registration-enabling clinical trial evaluating the safety and efficacy of its anti-PD-L1 antibody, cosibelimab, administered as a fixed dose of 800 mg every two weeks in patients with metastatic cutaneous squamous cell carcinoma (“cSCC”).
PharmD Live
JANUARY 25, 2022
PharmDs Earn MVP Status . By Marshall Eidenberg, OD. Chronic care services managed by a doctor of pharmacy, PharmD, is a critical addition to a medical practice, but they are not widely engaged with these responsibilities. With the challenging number of diagnoses and medications that Medicare patients take, it is essential to have a team member whose primary function is to rapidly review patients records, give informed advice on any side effects to watch out for, and give medication interaction
pharmaphorum
JANUARY 25, 2022
Oskar Möbert, Vice President OpenData Europe at Veeva Systems, tells us how they are reimagining customer reference data to boost pharma rep productivity, enable more personalised engagement, and increase patient reach. The medical landscape is generally becoming more complex, both in terms of the range of stakeholders involved in patient care and the rapid explosion of engagement channels. “Our customers need to make decisions based on insights powered by a deep understanding of their tar
Fierce Healthcare
JANUARY 27, 2022
GAO calls for major reforms at HHS to better prepare for future health emergencies. rking. Thu, 01/27/2022 - 16:39.
Pharma Mirror
JANUARY 25, 2022
PRINCETON, N.J. and BANGALORE, India, Indegene, a technology-led healthcare solutions provider today announced it established new Global Development Centers in Mexico, Poland and Ukraine to enable life sciences organizations accelerate their digital transformation. The life sciences industry is witnessing tremendous change with a growing focus on personalization, transformation of go-to-market models, and rapid adoption of real-world data and evidence to improve health outcomes.
Birth Control Pharmacist
JANUARY 24, 2022
Pharmacists in the community setting may soon have the opportunity to ease access to medication abortion in the United States. In the coming months, mifepristone (Mifeprex) is anticipated to have an updated Risk Evaluation and Mitigation Strategy (REMS) Program that allows dispensing through local brick-and-mortar and mail-order pharmacies. This change will integrate pharmacists into abortion care and bring them to the forefront of the national discussion about reproductive rights.
pharmaphorum
JANUARY 26, 2022
The final numbers are in, and now it’s official – digital health companies raked in a massive $57.2 billion in funding last year, beating prior records with a 79% increase over 2020. The data from CB Insights’ annual State of Digital Health report notes that the record investments were apparent across all geographies and were “fuelled by the growing need to provide digital solutions and delivery models to patients during the pandemic.” Highlights of the year included an a
Fierce Healthcare
JANUARY 28, 2022
Most health systems still base doctors' pay on volume, despite push towards value-based care: study. hlandi. Fri, 01/28/2022 - 07:12.
The Luxe Pharmacist
JANUARY 23, 2022
Hi everyone! If you’re in the field of pharmacy or healthcare in general, you’ve probably heard of board certifications or becoming board certified as a pharmacist. What you might not know however, is why becoming board certified is worth doing so or how it can help your career. After all the exam does cost $600 to take plus a renewal fee each year and specific continued education requirements to remain board certified.
Expert insights. Personalized for you.
139 
Let's personalize your content